BAY-509062

N/A

Report date: 2024/12/05 15:15:08

NME

Base Information

Drug NameBAY-509062

Drug Alias NameBAY-50-9062

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action17-hydroxysteroid dehydrogenases inhibitors

Targets17-hydroxysteroid dehydrogenases

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A